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Evaluation des World Health Organization Disability Assessment 
Schedule II (WHODAS II) – Deutsche Version  
Funktionale Gesundheit und Behinderung bei Patienten mit muskuloskeletalen 
Erkrankungen, kardiovaskulären und allgemeinen internistischen Erkrankungen, 
Schlaganfall, Brustkrebs und Depressiven Störungen 
 
 
ZUSAMMENFASSUNG 
 
Hintergrund: 
Der Fragebogen World Health Organization Disability Assessment Schedule II (WHODAS II) ist 
ein neues Messinstrument zur Erfassung von funktionaler Gesundheit und Behinderung, das 
konzeptuell mit dem Klassifikationssystem International Classification of Functioning, Disability 
and Health (ICF) übereinstimmt. Im Gegensatz zu anderen Instrumenten zur Erfassung des 
Gesundheitszustandes basiert der Fragebogen WHODAS II auf einem internationalen Klassifi-
kationssystem, kann kulturübergreifend eingesetzt werden und behandelt alle Krankheiten 
gleichwertig bei der Bestimmung der funktionalen Gesundheit.  
 
Zielsetzung: 
Ziel der vorliegenden Arbeit ist es, herauszufinden, inwieweit der Fragebogen World Health Or-
ganization Disability Assessment Schedule II (WHODAS II) – deutsche Version - ein geeignetes 
Messinstrument zur Erfassung von funktionaler Gesundheit und Behinderung bei Patienten mit 
muskuloskeletalen Erkrankungen, kardiovaskulären und allgemeinen internistischen Erkrankun-
gen, Schlaganfall, Brustkrebs und Depressiven Störungen ist. Spezifische Ziele sind dabei die 
Bewertung der psychometrischen Gütekriterien Reliabilität (internale Konsistenz, Cronbach’s 
Alpha), Validität (Faktorenanalyse zur Beurteilung der Dimensionalität, konvergente Validität, 
diskriminante Validität) und Änderungssensitivität (Effektstärke, Standardized Response Mean), 
die Bestimmung der Korrelation mit einem traditionellen generischen Messinstrument für ge-
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sundheitsbezogene Lebensqualität, dem SF36 und die Bestimmung der Änderungssensitivität 
nach einer rehabilitativen Behandlung, wiederum in Relation zum SF-36. 
 
Methoden: 
Patienten mit muskuloskeletalen Erkrankungen, kardiovaskulären und allgemeinen internisti-
schen Erkrankungen, Schlaganfall, Brustkrebs und Depression nahmen an der Studie teil. Diese 
Patienten füllten die Fragebogen WHODAS II und SF-36 aus. Nach einer rehabilitativen Thera-
pie beantworteten diese Patienten die Fragenbogen ein zweites Mal, damit Rückschlüsse auf 
die Veränderungssensitivität gezogen werden können. Analysen der Testgütekriterien wurden 
durchgeführt. Die Änderungssensitivität wurde anhand der Effektstärke und des SRM berech-
net.  
 
Ergebnisse: 
Die Patienten erreichen einen Mittelwert von 21,98 (Std. 14,32) in der Gruppe der muskuloske-
letalen Erkrankungen, 18,47 (Std. 15,32) in der Gruppe der internistischen Erkrankungen, 38,72 
(Std. 24,79) in der Subgruppe Schlaganfall, 23,84 (Std. 16,61) in der Subgruppe Brustkrebs und 
44,56 (Std. 18,95) in der Subgruppe Depressive Störungen. Der Fragebogen weist eine hohe 
Reliabilität auf. Größtenteils bestätigen die Ergebnisse der Skalenreplikation die vorgegebenen 
sechs Dimensionen des Fragebogens. In der Dimension „Aktivitäten des täglichen Lebens“ zeigt 
sich für die Subgruppen muskuloskeletale Erkrankungen und internistische Erkrankungen eine 
klare Trennung zwischen beruflichen Tätigkeiten und Tätigkeiten im Haushalt. Die im Vergleich 
mit dem SF-36 festgestellten Korrelationen deuten darauf hin, dass der Fragebogen WHODAS 
II die beabsichtigten Konstrukte misst. Die Effektstärken des Summenscores von WHODAS II 
reichen abhängig von der untersuchten Subgruppe von 0,163 bis 0,687; Effektstärken der 
Summenskalen des SF-36 von 0,025 bis 1,395. Für die Subgruppe der Patienten, die eine Ver-
besserung hinsichtlich ihres allgemeinen Gesundheitszustandes berichten, sind die Effektstär-
ken entsprechend höher (0,220 bis 0,915 für den WHODAS II; 0.083 bis 2.023 für den SF-36). 
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Schlussfolgerung: 
Der Fragebogen WHODAS II (deutsche Version) ist ein geeignetes Messinstrument zur Erfas-
sung von funktionaler Gesundheit und Behinderung bei Patienten mit muskuloskeletalen Er-
krankungen, kardiovaskulären und allgemeinen internistischen Erkrankungen, Schlaganfall, 
Brustkrebs und Depressiven Störungen. Das Messinstrument ist reliabel und valide und weist 
eine ähnliche Änderungssensitivität auf wie die entsprechenden Subskalen des SF-36. 
 
Schlüsselwörter: ICF, WHODAS II, Lebensqualität, Rückenschmerzen, Rheumatoide Arth-
ritis, Osteoarthritis, koronare Herzerkrankung, COPD & Asthma, Diabetes Mellitus, Adi-
positas, Brustkrebs, Schlaganfall, Depressive Störung, Änderungssensitivität 
 8 
Evaluation of the World Health Organization Disability Assessment 
Schedule II (WHODAS II) – German Version  
Functioning and Disability in Patients with Musculoskeletal Diseases, Cardiovas-
cular and General Internal Diseases, Stroke, Breast Cancer and Depressive Disor-
der 
 
 
ABSTRACT 
 
Backgroud: 
The World Health Organization Disability Assessment Schedule II (WHODAS II) is a new meas-
ure of functioning and disability that is conceptually compatible with the International Classifica-
tion of Functioning, Disability, and Health (ICF). In contrast to other measures of health status, 
the WHODAS II is based on an international classification system, it is designed to be applicable 
across different cultures, and it treats all disorders at parity when determining the level of func-
tioning. 
 
Objective: 
The general objective of this study is to investigate whether the WHODAS II – German version – 
is a useful instrument for measuring functioning and disability in patients with musculoskeletal 
conditions, cardiovascular and general internal conditions, stroke, breast cancer and depressive 
disorder. Specific objectives are to assess its psychometric properties reliability (internal consis-
tency, Cronbach's Alpha), validity (factor analysis of dimensionality, convergent validity, dis-
criminant validity), and sensitivity to change (effect size and standardized response mean), to 
determine to what extent the WHODAS II correlates with a traditional generic instrument for 
measuring Health Related Quality of Life, the SF-36, and to define its sensitivity to change after 
a rehabilitative intervention in relation to that other instrument. 
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Methods: 
Patients with musculoskeletal conditions, cardiovascular and general internal conditions, stroke, 
breast cancer and depressive disorder participated. The patients completed the questionnaires 
WHODAS II and SF-36. After a rehabilitation treatment the same patients completed these 
questionnaires again in order to assess sensitivity to change. Analyses of measurement proper-
ties were conducted. Sensitivity to change was calculated by the effect size (ES) and standard-
ized response mean (SRM).  
 
Results: 
Mean score on the WHODAS II is 21.98 (SD 14.32) for musculoskeletal conditions, 18.47 (SD 
15.32) for internal conditions, 38.72 (SD 24.79) for stroke, 23.84 (SD 16.61) for breast cancer, 
and 44.56 (SD 18.95) for depressive disorder. High reliability is obtained. For the most part, the 
results of the scale replication confirm the determined six domains of the questionnaire. For the 
domain Activities, a clear distinction between work und household activities is apparent in both 
musculoskeletal and internal conditions. The correlations found in comparison to the SF-36 indi-
cated that the WHODAS II (German version) measured indeed the expected constructs. The 
effect sizes of the WHODAS II Total Score range from 0.163 to 0.687 depending on the sub-
group; effect sizes of the SF-36 summary scores from 0.025 to 1.395, respectively. In terms of 
patients reporting an improvement of general health status, effect sizes are accordingly higher 
(0.220 to 0.915 for the WHODAS II; 0.083 to 2.023 for the SF-36). 
 
Conclusion: 
The WHODAS II (German version) is a useful instrument for measuring functioning and disabil-
ity in patients with musculoskeletal diseases, internal diseases, stroke, breast cancer and de-
pressive disorder. It is reliable and valid and shows similar sensitivity to change scores as the 
SF-36 in the accordingly subscales. 
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Key Indexing Terms: ICF, WHODAS II, Quality of Life, Low Back Pain, Rheumatoid Arthri-
tis, Osteoarthritis, Coronary Heart Disease, COPD & Asthma, Diabetes Mellitus, Obesity, 
Breast Cancer, Stroke, Depressive disorder, Sensitivity to Change 
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BACKGROUND 
The World Health Organization (WHO) has revised the International Classification of Impair-
ments, Disabilities and Handicaps (ICIDH) towards a biopsychosocial model – the International 
Classification of Functioning, Disability, and Health (ICF) – to comprehend human functioning at 
physical, personal, and social levels (1). In order to evaluate function and disability, the WHO has 
developed the World Health Organization Disability Assessment Schedule II (WHODAS II) (2) as 
an instrument that arises from the same conceptual basis as the ICF. In the ICF disability is un-
derstood independent of the background disease or health condition and etiologically neutral. 
The ICF and WHODAS II share the same conceptual understanding of disability and its dimen-
sions. The WHODAS II is a multidimensional questionnaire, which can be employed for measur-
ing the level of disability across various conditions and interventions. It includes six domains: 
Understanding and Communicating, Getting Around, Self Care, Getting Along with Others, 
Household and Work Activities, Participation in Society. The WHODAS II has been translated 
and validated in numerous languages. Versions of the WHODAS II can be obtained through the 
WHO. The WHODAS II as a generic instrument should be applicable for all types of diseases, 
therefore we examined to what extent the WHODAS II would be a useful questionnaire in as-
sessing disability in several different diseases, namely musculoskeletal conditions (low back 
pain, rheumatoid arthritis and osteoarthritis), cardiovascular and general internal conditions 
(coronary heart disease, COPD & asthma, diabetes mellitus, obesity), breast cancer, stroke and 
depressive disorder. Critical properties of an outcome measure include reliability, validity and 
sensitivity to change. According to Guyatt & Kirshner (3) goals of clinical measurement instru-
ments are discrimination, prediction and evaluation. Within instruments that are employed for 
evaluation, the classical measurement properties objectivity, reliability and validity are not suffi-
cient. Sensitivity to change must be ensured. 
Outside of the WHO centers where this questionnaire was developed and tested, there has not 
yet been a large validation study incorporating numerous different diseases. The work presented 
here is the first independent attempt to confirm or refute those findings across a broad range of 
health conditions. 
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The general objective of this study is to investigate whether the WHODAS II – German version – 
is a useful instrument for measuring functioning and disability. Specific objectives are to assess 
its psychometric properties reliability, validity, and sensitivity to change, to determine to what 
extent the WHODAS II correlates with another generic instrument, the SF-36, and to define its 
sensitivity to change after a rehabilitative intervention in relation to that other instrument. As an 
external validation we employed the widely used generic instrument, the Short Form-36 Health 
Status Questionnaire (SF-36), which is used for measuring quality of life in patients suffering 
from the above mentioned conditions.  
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MATERIALS AND METHODS 
♦ Design 
Analyses were performed on basis of data of a multicenter, prospective cohort study with two 
time points of assessment (prior to rehabilitative treatment and after).  
 
♦ Patients 
The validation of the WHODAS II refers to two different condition groups: musculoskeletal 
conditions (low back pain, rheumatoid arthritis, osteoarthritis), cardiovascular and general 
internal conditions (coronary heart disease, COPD & asthma, diabetes mellitus, obesity). 
Three conditions were tested separately due to their relevance: breast cancer, stroke and de-
pressive disorder (Table 1). N = 904 inpatients of 19 rehabilitation centers and clinics in Bavaria, 
Germany were included. These patients were suffering from at least one of the conditions men-
tioned above. 
Table 1: Conditions and ICD-10 Diagnoses 
 
Condition ICD-10 Diagnosis 
Condition Group: Musculoskeletal Conditions 
Low Back Pain Dorsalgia (M54) 
Rheumatoid Arthritis Rheumatoid Arthritis (M05-M06) 
Osteoarthritis Osteoarthritis (M19) 
Condition Group: Cardiovascular and General Internal Conditions 
Coronary Heart Disease  Myocardial Infarction (I21-I25) 
Other Chronic Obstructive Pulmonary Disease (J44) COPD & Asthma 
Asthma (J45) 
Diabetes Mellitus Diabetes Mellitus (E10-E14) 
Obesity Obesity (E65-E68) 
Single Conditions 
Stroke, not Specified as Haemorrhage or Infarction (I64) Stroke 
Consequence of Stroke (I69.4) 
Breast Cancer Malignant Neoplasm of Breast (C50) 
Depressive Episode (F32) Depressive Disorder 
Recurrent Depressive Disorder (F33) 
 
Inclusion criteria were 1) age ≥ 18, 2) main diagnosis of the patients corresponds to one of the 
ICD-10 diagnosis listed in Table 1, 3) purpose and reason for the study have been understood, 
and 4) signed informed consent has been provided. Patients who have had surgery and wound 
 14 
has not completely healed yet and patients who have had surgery within the previous six 
months were excluded. 
 
♦ Data Collection Procedures 
The self-administration form of the WHODAS II and the SF-36 was filled in by the patients on 
their own. Health professionals were available for possible questions. 
 
♦ Measures 
WHODAS II 
The World Health Organization Disability Assessment Schedule II (WHODAS II) is a measure of 
functioning and disability that is conceptually compatible with ICF (1). This measurement instru-
ment assesses functioning/disability across a variety of conditions and treatment interventions in 
six domains of life: Understanding and Communicating (cognition), Getting Around (mobility), 
Self Care (attending to one’s hygiene, dressing, eating and staying alone), Getting Along with 
Others (interpersonal interactions), Household and Work Activities (domestic responsibilities, 
leisure, and work), Participation in Society (joining in community activities) during the last 30 
days. Both a profile of functioning across these domains and an overall disability score is pro-
vided. We used the self-administered 36-item version of the WHODAS II in German. The WHO-
DAS II consists of 36 Likert formatted questions, divided into the above-mentioned six domains. 
The final scores are calculated with an SPSS syntax. These scores range from 0 (best) to 100 
(worst). 
 
The Short Form-36 Health Survey 
The SF-36 Health Survey (4) is a short-form health survey developed for the Medical Outcome 
Study (5), that is validated and normed for numerous countries. It contains 36 questions and pro-
duces an eight-scale profile of scores: Physical Functioning (limitations in physical activities be-
cause of health problems), Role Functioning-Physical (limitations in usual role activities due to 
physical health problems), Bodily Pain, General Health, Vitality (energy and fatigue), Social 
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Functioning (limitations in social activities due to physical or emotional problems), Role Func-
tioning-Emotional (limitations in usual role activities due to emotional problems), and Mental 
Health (psychological distress and well-being). Furthermore the SF-36 provides a summary 
physical and a summary mental score, each consisting of four scales. The SF-36 is a generic 
measure of health status and has proven useful in comparing general and specific populations, 
estimating the relative burden of diseases, differentiating the health benefits resulting from dif-
ferent treatments, and screening individual patients (6). The patients complete the self-
administration form of this questionnaire. 
 
♦ Analysis 
Data were analyzed using SPSS 11.0 for Windows. The WHODAS II was assessed in terms of 
psychometric properties: reliability (internal consistency, Cronbach's Alpha), validity (factor 
analysis of dimensionality, convergent validity, discriminant validity), sensitivity to change in rela-
tion to another traditional generic instrument, the SF-36. 
 
Descriptive Analyses (M, SD, Min, Max) were conducted. 
 
Missing Values Analysis 
Missing data refers to information not available for a subject (or case) about whom other infor-
mation is available (7). Missing data might be caused by the respondent’s refusal to answer one 
or more questions. The rate of missing data is a criterion for the assessment of the data set’s 
quality. A high percentage of missing data leads to an uncontrollable sample selection and limits 
the meaningfulness of the individual scales considerably. A rate of more than 10% of missing 
data is considered as a criterion for a meaningful and thus critical missing rate, as is the sys-
tematic appearance of missings (8). 
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Floor- and Ceiling Effects 
Analyses regarding floor- and ceiling effects were conducted. Appearance of floor- and ceiling 
effects leads to the following (8): Distinction between patients that show extreme values is not 
possible even if they actually differ regarding to the underlying construct. A false impression of 
homogeneity arises from it regarding the measured value. Distinctive floor-and ceiling effects 
reduce both the reliability and the validity of an instrument since they reduce its variability. In the 
course of the study, improvements or deteriorations of health state in patients with extreme 
characteristics are not detectable. This might lead to an underestimation of the treatment effect, 
i.e. to a lower responsiveness. Concluding that patients are not improving, when in fact, they are 
indeed making clinically significant changes, which cannot be detected by the measurement tool 
can lead to poor administrative and clinical decisions.  
 
Reliability 
An important step in instrument validation is to test the instrument for reliability to ensure meas-
urement accuracy in order to minimize the measurement error. Cronbach's Alpha, which is cal-
culated based on the average inter-item correlations (9), was estimated for each of the subscales 
in every sample to measure internal consistency. 
 
Factor Analysis 
Kaiser-Mayer-Olkin’s Measure of Sampling Adequacy Test and Bartlett’s Test of Sphericity were 
conducted to assess the suitability of the data for factor analysis. The Kaiser-Mayer-Olkin 
Measure of Sampling Adequacy is a statistic that indicates the proportion of variance in the vari-
ables which is common variance, i.e. which might be caused by underlying factors. This index 
ranges from 0 to 1, reaching 1 when each variable is perfectly predicted without error by the 
other variables. The measure can be interpreted with the following guidelines: 0.9 or above is 
marvelous, 0.8 is meritorious, 0.7 is middling, 0.6 is mediocre, 0.5 is miserable and below 0.5 is 
unacceptable (10, 11). 
 17 
The Bartlett Test of Sphericity is a statistical test for the presence of correlations among the 
variables (items). It shows whether the correlation matrix is an identity matrix, which indicates 
that the variables (items per specific construct) are unrelated. The significance level gives the 
result of the test. Small values indicate that the data do not produce an identity matrix and, 
hence, are suitable for factor analysis. The results of Kaiser-Mayer Olkin’s Measure of Sampling 
Adequacy and Bartlett Tests show that the data meet the fundamental requirements for factor 
analysis. For adequate subgroups a Principal Component Analysis with Varimax-Rotation with 
Kaiser Normalization and extraction of 6 factors was performed in order to show a replication of 
the dimensionality of WHODAS II. 
 
Inter-Scale Correlations 
In order to further test the dimensionality of WHODAS II, correlations (Pearson correlation coef-
ficients) of the subscales and the Total Score were examined. Since the domains reflect the 
same construct (disability, functioning and health), they should be correlated positively and suffi-
ciently. As they should not obtain redundant information, very high correlations are not desir-
able. 
 
Convergent Validity 
Convergent validity is defined as the degree to which the operationalization is similar to (con-
verges on) other operationalizations that it theoretically should be similar to. The convergent 
validation was examined through correlation of the subscales with comparable scales of the SF-
36. Convergent validity was estimated by Pearson correlation coefficients. Consistent with litera-
ture on convergent validity, Pearson correlation coefficient values greater than 0.7 were consid-
ered to reflect a high degree of correlation; values between 0.5 and 0.7 were regarded to reflect 
moderate correlation (12). 
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Discriminant Validity 
The discriminant validity was assessed by a differentiation of the study population according to 
criteria that assume a difference regarding functioning and severity of disease. The grouping 
variable (discrete classification variable) was an item assessing the degree of Sensation of Pain 
(b280) in the International Classification of Function, Disability and Health (ICF). Answer possi-
bilities ranged from 0 to 4 (no/mild/moderate/severe/complete impairment, respectively). The 
ICF Checklist was completed by health professionals in cooperation with the patients. Patients 
were classified into two groups, no/mild pain (0-1) and strong pain (3-4). If the number of pa-
tients in the subgroups differed very much, additional analyses were conducted according to the 
following criteria: patients were classified into two groups, no/mild pain (0-1) and moderate to 
strong pain (2-4). The purpose of this analysis was to investigate independent variable mean 
differences between groups formed by the dependent variable, to determine the percent of vari-
ance in the dependent variable explained by the independents, to assess the relative impor-
tance of the independent variables in classifying the dependent variable and to test the theory 
(discriminant function) by observing whether cases are classified as predicted (13). For compari-
son reasons the discriminant analysis was performed for scales of the SF-36 as well. 
 
Sensitivity to Change 
According to Liang et al. (14) sensitivity to change is the ability of an instrument to detect changes 
over time. As opposed to that responsiveness is the ability of an instrument to measure a mean-
ingful or important change in a clinical state. Sensitivity to change provides the basis for compar-
ing measures with differing scales and can be measured using variables such as effect size (15) 
and standardized response mean (16). The ability of an instrument to discern these changes can 
be evaluated either over a prespecified period of time or by comparison to a well-established 
physiologic measure. Since there is no external commonly accepted standard for disability, in 
the article at hand sensitivity of the WHODAS II was defined as internal sensitivity, which char-
acterizes the ability of a measure to change over specified time frame. Additional effect sizes for 
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patients who assessed their perceived general health status better than before the rehabilitation 
treatment were analyzed. Improvement was defined as a better score in item 1 (general health) 
of the SF-36 after rehabilitation treatment. First, effect sizes were calculated for each subscale 
and the summary score of the WHODAS II and SF-36. Effect sizes were calculated as the 
change in mean from baseline (time 1) to the follow-up (time 2) divided by the standard devia-
tion at baseline (15). According to the literature, effect sizes of 0.2 to 0.5 are considered to reflect 
small responsiveness, effect sizes of 0.5 to 0.8 were regarded as being moderate and those 
greater than or equal to 0.8 as being large (17, 18). Sensitivity of instruments may also be directly 
compared in that the standardized response means (SRMs) of two instruments are compared 
(14). Standardized response mean is defined as mean score change divided by the standard de-
viation of the change score (16, 19). The more sensitive instrument should have a larger SRM 
 20 
 
RESULTS 
 
♦ Demographic Information and Baseline Characteristics 
Demographic Information 
Demographic data and information on health status of the n=904 patients included are shown in 
Table 2 to 7. Patients (N=296) with musculoskeletal conditions were examined (cardiovascular 
and general internal conditions: N= 308, stroke: N= 116, breast cancer: N= 119, depression: N= 
65) (Table 2). The percentage of females is 50% for the musculoskeletal conditions, 40.26% for 
internal conditions, 47.41% for stroke, 100% for breast cancer and 32.3% for depression (Table 
3). The age ranges of patients are between 19 and 83 years in musculoskeletal conditions 
(mean 54, SD 11.28), 17 to 82 for internal conditions (mean 51.78, SD 15.14), 20 to 80 for 
stroke (mean 57.30, SD 12.43), 30 to 77 for breast cancer (mean 53.62, SD 9.59) and 23 to 70 
for depression (mean 48.3, SD 9.48), respectively, see Table 4. Of all patients, 31% to 63.5% 
are employed and 9.2% to 42.2% of the subjects are retired (Table 5). 
 
Table 2: Diagnoses, Number of Patients 
Multiple diagnoses were possible. 
 
Musculoskeletal Conditions 
 n (N=296) % 
Low back pain 200 67.60 
Osteoporosis 0 0.00 
Rheumatoid arthritis 40 13.50 
Osteoarthritis 62 20.90 
Coronary heart disease 1 0.30 
COPD & asthma bronchiale 0 0.00 
Diabetes mellitus 1 0.30 
Obesity 8 2.70 
Pain disorders 4 1.40 
Stroke 0 0.00 
Breast cancer 2 0.70 
Depressive disorder 1 0.30 
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Table 2 cont.   
Internal Conditions 
 n (N=308) % 
Low back pain 8 2.60 
Osteoporosis 0 0.00 
Rheumatoid arthritis 0 0.00 
Osteoarthritis 3 1.00 
Coronary heart disease 80 26.00 
COPD & asthma bronchiale 92 29.90 
Diabetes mellitus 77 25.00 
Obesity 67 21.80 
Pain disorders 3 1.00 
Stroke 0 0.00 
Breast cancer 0 0.00 
Depressive disorder 2 0.60 
Stroke 
 n (N=116) % 
Low back pain 0 0.00 
Osteoporosis 0 0.00 
Rheumatoid arthritis 0 0.00 
Osteoarthritis 0 0.00 
Coronary heart disease 0 0.00 
COPD & asthma bronchiale 0 0.00 
Diabetes mellitus 0 0.00 
Obesity 0 0.00 
Pain disorders 0 0.00 
Stroke 116 100.00 
Breast cancer 0 0.00 
Depressive disorder 0 0.00 
Breast Cancer 
 n (N=119) % 
Low back pain 2 1.70 
Osteoporosis 0 0.00 
Rheumatoid arthritis 0 0.00 
Osteoarthritis 0 0.00 
Coronary heart disease 0 0.00 
COPD & asthma bronchiale 0 0.00 
Diabetes mellitus 0 0.00 
Obesity 0 0.00 
Pain disorders 0 0.00 
Stroke 0 0.00 
Breast cancer 119   100.00 
Depressive disorder 0 0.00 
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Table 2 cont.   
Depression 
 n (N=65) % 
Low back pain 1 1.50 
Osteoporosis 0 0.00 
Rheumatoid arthritis 0 0.00 
Osteoarthritis 0 0.00 
Coronary heart disease 0 0.00 
COPD & asthma bronchiale 0 0.00 
Diabetes mellitus 0 0.00 
Obesity 2 3.10 
Pain disorders 13 20.00 
Stroke 0 0.00 
Breast cancer 0 0.00 
Depressive disorder 65 100.00 
 
Table 3: Gender 
Musculoskeletal Conditions 
   
  n (N=296) % 
Male 148 50.00 
Female 148 50.00 
Missing 0 0.00 
Total 296 100.00 
Internal Conditions 
   
  n (N=308) % 
Male  179 57.47 
Female 127 40.26 
Missing 2 2.27 
Total 308 100.00 
Stroke 
   
  n (N=116) % 
Male 61 52.59 
Female 55 47.41 
Missing 0 0.00 
Total 116 100.00 
Breast Cancer 
   
  n (N=119) % 
Male 0 0.00 
Female 119 100.00 
Missing 0 0.00 
Total 119 100.00 
Depression 
   
  n (N=65) % 
Male 44 67.70 
Female 21 32.30 
Missing 0 0.00 
Total 65 100.00 
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Table 4: Age 
Musculoskeletal Conditions  
  n (N=296) 
N 296 
Min 19.83 
Max 83.50 
Mean  54.00 
SD 11.28 
Internal Conditions  
  n (N=308) 
N 308 
Min 17.87 
Max 82.76 
Mean  51.78 
SD 15.14 
Stroke  
  n (N=116) 
N 116 
Min 20.50 
Max 80.92 
Mean  57.30 
SD 12.43 
Breast Cancer 
  
  n (N=119) 
N 119 
Min 30.59 
Max 77.09 
Mean  53.62 
SD 9.59 
Depression  
  n (N=65) 
N 65 
Min 23.38 
Max 70.74 
Mean  48.30 
SD 9.48 
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Table 5: Current Occupation 
Musculoskeletal Conditions    
 n (N=296) % 
Paid employment 188 63.51 
Self-employed 11 3.72 
Non-paid employment 1 0.34 
Student 0 0.00 
House maker 13 4.39 
Retired 63 21.28 
Unemployed (due to health reasons) 8 2.70 
Unemployed (due to other reasons) 8 2.70 
Other 3 1.01 
Missing 1 0.30 
Total 296 100.00 
Internal Conditions    
 n (N=308) % 
Paid employment 147 47.70 
Self-employed 10 3.20 
Non-paid employment 0 0.00 
Student 10 3.20 
House maker 14 4.50 
Retired 85 27.60 
Unemployed (due to health reasons) 7 2.30 
Unemployed (due to other reasons) 14 4.50 
Other 14 4.50 
Missing 7 2.30 
Total 147 47.70 
Stroke    
 n (N=116) % 
Paid employment 36 31.00 
Self-employed 5 4.30 
Non-paid employment 1 0.90 
Student 0 0.00 
House maker 5 4.30 
Retired 49 42.20 
Unemployed (due to health reasons) 6 5.20 
Unemployed (due to other reasons) 0 0.00 
Other 7 6.10 
Missing 7 6.00 
Total 116 100.00 
 
 
 
 
 
 
 
 
 
 
 
  
 25 
Table 5 cont.   
Breast Cancer    
 n (N=119) % 
Paid employment 56 47.06 
Self-employed 2 1.68 
Non-paid employment 0 0.00 
Student 0 0.00 
House maker 23 19.33 
Retired 20 16.81 
Unemployed (due to health reasons) 10 8.40 
Unemployed (due to other reasons) 8 6.72 
Other 0 0.00 
Missing 0 0.00 
Total 56 47.06 
Depression    
 n (N=65) % 
Paid employment 40 61.50 
Self-employed 5 7.70 
Non-paid employment 0 0.00 
Student 1 1.50 
House maker 1 1.50 
Retired 6 9.20 
Unemployed (due to health reasons) 7 10.80 
Unemployed (due to other reasons) 1 1.50 
Other 3 4.60 
Missing 1 1.50 
Total 65 100.00 
 
Descriptive Statistics 
Mean, SD 
As displayed in Table 6 mean score of the WHODAS II is 21.98 (SD 14.32) for musculoskeletal 
conditions, 18.47 (SD 15.32) for internal conditions, 38.72 (SD 24.8) for stroke, 23.84 (SD 
16.61) for breast cancer and 44.56 (SD 18.95) for depression. All subgroups show greatest im-
pairments concerning the subscales Activities or Participation. The least impairment was ob-
tained in terms of Self Care and Getting Along with Others. 
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Table 6: Descriptive Statistics at Baseline 
 WHODAS II 
Musculoskeletal Conditions           
WHODAS II N Min Max Mean Std 
Understanding and Communicating 292 0.00 75.00 17.52 17.55 
Getting Around 293 0.00 95.00 29.64 21.78 
Self Care 293 0.00 87.50 8.72 15.10 
Getting Along with Others 291 0.00 91.67 12.43 15.21 
Activities 288 0.00 100.00 33.12 24.96 
Participation 293 0.00 75.00 23.51 17.32 
Total Score 285 0.00 80.79 21.98 14.32 
Internal Conditions  
     
WHODAS II N Min Max Mean Std 
Understanding and Communicating 298 0.00 100.00 18.81 17.78 
Getting Around 302 0.00 100.00 19.51 20.38 
Self Care 303 0.00 100.00 6.47 14.97 
Getting Along with Others 297 0.00 100.00 13.93 16.58 
Activities 293 0.00 100.00 22.73 24.27 
Participation 297 0.00 100.00 23.15 19.36 
Total Score 286 0.00 100.00 18.47 15.32 
Stroke  
     
WHODAS II N Min Max Mean Std 
Understanding and Communicating 107 0.00 95.00 31.26 23.79 
Getting Around 109 0.00 100.00 42.20 34.58 
Self Care 109 0.00 100.00 30.58 31.90 
Getting Along with Others 109 0.00 100.00 24.60 24.39 
Activities 102 0.00 100.00 53.24 35.39 
Participation 108 0.00 100.00 41.18 25.31 
Total Score 101 0.00 94,31 38.72 24.80 
Breast Cancer  
     
WHODAS II N Min Max Mean Std 
Understanding and Communicating 118 0.00 75.00 23.80 18.79 
Getting Around 118 0.00 85.00 19.48 18.99 
Self Care 118 0.00 68.75 7.42 13.23 
Getting Along with Others 118 0.00 90.00 18.65 17.33 
Activities 118 0.00 100.00 34.33 27.30 
Participation 117 0.00 90.63 27.75 19.39 
Total Score  117 0.00 69.45 23.84 16.61 
Depression  
     
WHODAS II N Min Max Mean Std 
Understanding and Communicating 65 8.33 87.50 48.17 21.36 
Getting Around 65 0.00 90.00 30.22 26.70 
Self Care 65 0.00 100.00 16.44 20.15 
Getting Along with Others 65 0.00 90.00 44.58 25.43 
Activities 64 3.13 100.00 54.26 25.58 
Participation 65       10.71 95.83 54.46 19.79 
Total Score  64 9.72 89.58 44.56 18.95 
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Health Related Quality of Life was examined by the SF-36 (Table 7). Greatest impairments are 
reported in the domain Role Functioning-Physical by patients with musculoskeletal conditions 
and breast cancer, in the domain Vitality by patients with internal conditions and stroke. Patients 
in the depression group show lowest values on the Mental Health scale. These findings corre-
spond with the main characteristics of these diseases, which are mastering physical challenges 
and psychological challenges, respectively. Least impairment (i.e. best health status) is obtained 
regarding Role Functioning-Emotional in the musculoskeletal and internal conditions. Patients 
with stroke and breast cancer experience least impairment in Social Functioning, whereas pa-
tients with depression have best values concerning Physical Functioning. With respect to the 
scales Role Functioning-Emotional and Social Functioning patients across subgroups report the 
best health status. Regarding the summary measures patients report stronger impairment in the 
Physical Health Index Score than in the Mental Health Index Score, except patients suffering 
from depression. 
 
 
Table 7: Descriptive Statistics at Baseline 
 SF-36 
Musculoskeletal Conditions       
SF-36 N Min Max Mean Std 
Physical Functioning 292 0.00 100.00 59.59 25.41 
Role Functioning-Physical 289 0.00 100.00 33.28 38.24 
Bodily Pain 294 0.00 100.00 35.27 19.43 
General Health 287 0.00 87.00 49.39 17.63 
Vitality 291 0.00 90.00 43.01 17.99 
Social Functioning 294 0.00 100.00 71.13 25.81 
Role Functioning-Emotional 287 0.00 100.00 74.45 39.59 
Mental Health 289 0.00 100.00 62.60 19.61 
PHYSICAL HEALTH INDEX SCORE 280 7.18 57.23 34.12 9.96 
MENTAL HEALTH INDEX SCORE 280 11.50 73.76 48.45 11.47 
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Table 7 cont.      
Internal Conditions       
SF-36 N Min Max Mean Std 
Physical Functioning 305 0.00 100.00 66.01 27.59 
Role Functioning-Physical 292 0.00 100.00 49.09 43.08 
Bodily Pain 301 0.00 100.00 59.18 31.15 
General Health 296 0.00 97.00 50.12 19.77 
Vitality 297 0.00 100.00 48.64 20.57 
Social Functioning 304 0.00 100.00 73.27 26.21 
Role Functioning-Emotional 285 0.00 100.00 73.45 39.96 
Mental Health 293 10.00 100.00 64.91 20.58 
PHYSICAL HEALTH INDEX SCORE 273 14.44 62.62 40.62 11.37 
MENTAL HEALTH INDEX SCORE 273 11.97 69.70 47.47 11.60 
Stroke       
SF-36 N Min Max Mean Std 
Physical Functioning 107 0.00 100.00 43.67 33.90 
Role Functioning-Physical 96 0.00 100.00 22.66 37.71 
Bodily Pain 107 0.00 100.00 58.06 31.79 
General Health 104 0.00 97.00 45.69 20.10 
Vitality 103 0.00 100.00 38.92 23.37 
Social Functioning 107 0.00 100.00 60.51 27.96 
Role Functioning-Emotional 90 0.00 100.00 46.30 46.79 
Mental Health 99 8.00 100.00 55.44 21.72 
PHYSICAL HEALTH INDEX SCORE 82 14.46 57.48 35.15 10.20 
MENTAL HEALTH INDEX SCORE 82 18.19 71.20 42.06 12.06 
Breast Cancer       
SF-36 N Min Max Mean Std 
Physical Functioning 117 0.00 100.00 67.19 23.10 
Role Functioning-Physical 117 0.00 100.00 38.60 38.71 
Bodily Pain 118 0.00 100.00 59.84 27.45 
General Health 116 18.75 100.00 56.55 18.89 
Vitality 118 0.00 95.00 44.52 22.27 
Social Functioning 118 0.00 100.00 70.44 27.13 
Role Functioning-Emotional 114 0.00 100.00 62.57 44.60 
Mental Health 118 8.00 100.00 60.86 20.73 
PHYSICAL HEALTH INDEX SCORE 111 19.65 60.00 40.92 10.24 
MENTAL HEALTH INDEX SCORE 111 15.71 62.64 44.33 12.64 
Depression       
SF-36 N Min Max Mean Std 
Physical Functioning 65 0.00 100.00 65.75 28.11 
Role Functioning-Physical 62 0.00 100.00 37.90 39.66 
Bodily Pain 65 0.00 100.00 40.94 32.60 
General Health 64 0.00 87.00 39.11 19.21 
Vitality 65 0.00 55.00 21.69 12.48 
Social Functioning 65 0.00 100.00 31.54 22.00 
Role Functioning-Emotional 64 0.00 100.00 17.71 30.27 
Mental Health 65 0.00 68.00 31.18 16.90 
PHYSICAL HEALTH INDEX SCORE 62 22.19 69.99 41.86 11.86 
MENTAL HEALTH INDEX SCORE 62 8.97 47.62 24.42 8.57 
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Missing Values Analysis 
Missing values do not occur systematically and in most variables the missing value rate is below 
the critical limit of 10% (8). Regarding all variables, except questions concerning work activities 
and sexual activities, in the subgroup of patients with musculoskeletal conditions only 1% to 
4.4% of the items are missing data, in general and internal conditions 6% to 14.7%, in the sub-
group stroke 6% to 14.7%, in the subgroup breast cancer 0.8 to 7.6% and in the depression 
group 0% to 7.7%. Up to 65.5 % of answers are missing concerning work activities, partly due to 
unemployment. The question about sexual activities was not answered by up to 18.1%. 
 
Floor- and Ceiling-Effects 
In part, the ability to respond to change can be assessed in terms of the proportion of patients at 
floor (i.e. the worst score) or ceiling (i.e. the best score) of each scale (20).To assess the ability to 
respond to change the floor and ceiling effects were determined at baseline. The subscales of 
the WHODAS II show partially strong floor effects. In the domain Self Care, 33% to 70.3% of the 
patients report best possible score 0, i.e. no limitations, at baseline (Table 8). 
 
Table 8: Floor-Effects (Percentage of Patients Featuring the Score 0 in Subscales of WHODAS II at 
Baseline) 
Breast 
WHODAS II Musculo-skeletal Internal Stroke Cancer 
Depression
Understanding and Communicating 24.3 18.8 11.2 8.5 3.1 
Getting Around 8.2 24.5 16.5 20.3 20.0 
Self Care 56.0 70.3 33.0 61.0 35.4 
Getting Along with Others 37.8 34.0 22.9 20.3 4.6 
Activities 11.1 24.9 12.7 14.4 1.6 
Participation 6.1 7.7 3.7 7.7 1.5 
 
♦ Reliability 
Table 9 displays the results of the reliability analysis. The Cronbach's alpha values range from 
0.70 to 0.97. There is no standard cut-off point for the alpha coefficient, but the generally agreed 
upon lower limit for Cronbach's alpha is 0.7 required for group comparisons (7). Thus, all sub-
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scales meet the requirements. However, only the scales activities almost fulfill the level of 0.95 
across subgroups required for use in individual patients according to Nunally (21). When inter-
preting these values, one has to take the floor- and ceiling-effects into account, both of which 
bias the Cronbach’s alpha. 
 
Table 9 Cronbach’s Alpha 
Musculoskeletal Conditions  
WHODAS II Cronbach's Alpha 
Understanding and Communicating 0.87 
Getting Around 0.85 
Self Care 0.82 
Getting Along with Others 0.70 
Activities 0.94 
Participation 0.82 
Internal Conditions  
WHODAS II Cronbach's Alpha 
Understanding and Communicating 0.87 
Getting Around 0.84 
Self Care 0.87 
Getting Along with Others 0.72 
Activities 0.94 
Participation 0.87 
Stroke  
WHODAS II Cronbach's Alpha 
Understanding and Communicating 0.86 
Getting Around 0.95 
Self Care 0.92 
Getting Along with Others 0.84 
Activities 0.97 
Participation 0.87 
Breast cancer  
WHODAS II Cronbach's Alpha 
Understanding and Communicating 0.86 
Getting Around 0.84 
Self Care 0.70 
Getting Along with Others 0.69 
Activities 0.97 
Participation 0.88 
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Table 9 cont.  
Depression  
WHODAS II Cronbach's Alpha 
Understanding and Communicating 0.83 
Getting Around 0.91 
Self Care 0.70 
Getting Along with Others 0.81 
Activities 0.95 
Participation 0.77 
 
♦ Factor Analysis 
Factor Analysis was only conducted regarding musculoskeletal and internal conditions. The 
subgroups stroke, breast cancer and depression did not meet the requirements for factor analy-
sis, as explained below. 
The Kaiser-Mayer-Olkin’s Measure of Sampling Adequacy Test and Bartletts`s Test of Spheric-
ity: For both groups of diseases (musculoskeletal conditions and internal conditions) the Kaiser-
Mayer-Olkin’s (KMO) measure is 0.88, which is classified as “meritorious” (10, 11). A value close to 
1 indicates that patterns of correlations are relatively compact and factor analysis should yield 
distinct and reliable factors. Bartlett's Test is highly significant in both cases as well, and there-
fore factor analysis is appropriate. The groups stroke, breast cancer and depression show un-
satisfactory values regarding the KMO-Measure (smaller than 0.4, which is unacceptable ac-
cording to Kaiser (10)). According to the Subjects-to-Variables ratio (22) as well as to the rule of 
200 (23) the sample size of patients with stroke, breast cancer and depression is not sufficient. 
Thus, no factor analysis was conducted. In order to show a replication of the dimensionality of 
WHODAS II for musculoskeletal and internal conditions a Principal Component Analysis (PCA) 
with Varimax-Rotation with Kaiser Normalization and Extraction of 6 factors was performed. In 
Table 10 and 11, the communalities (h2) of the variables and their loadings on the factors are 
shown. For reasons of clarity, all loadings less than 0.3 are suppressed in the output. Regarding 
musculoskeletal conditions, the total variance explained by six factors is 63,89%. 
Replication of scales: The five items in the domain Understanding and Communicating have 
loadings on the same component, with item 1.3 (“solutions to problems in day to day life”) being 
a splitter-item, i.e. an item that loads comparably high onto different factors. Items of the sub-
scale Getting Around replicate one domain, while item 2.4 (“getting out of your home”) loads 
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onto another factor as well. Items of the domain Self Care do not replicate a scale. There are 
cross-loadings on factors with items of the domains Activity/Work and Getting Around. In the 
area Activities, there is a division between items that are related to accomplishing a job and 
those that are related to household activities. Job-related items show very high loadings (0.835 
to 0.870) onto one particular factor. Household-related items load onto a different factor with 
comparably high loadings. The domain Participation consists of splitter-items. Thus, the original 
scale could not be replicated. 
Table 10: Rotated Component Matrix, Musculoskeletal Conditions 
  h2 1 2 3 4 5 6 
D4.1 Getting Along, Dealing w people you don't know 0.557 0.713           
D4.4 Getting Along, Making new friends 0.571 0.690           
D1.6 Understanding, Starting conversation 0.670 0.685     0.403     
D4.2 Getting Along, Maintaining a friendship 0.540 0.652           
D4.3 Getting Along, People you are close to 0.487 0.597           
D6.1 Participation, Joining in community activities 0.582 0.556 0.369         
D6.3 Participation, Living with dignity 0.599 0.549         0.532
D6.2 Participation, Barriers or hindrances 0.523 0.505         0.479
D6.7 Participation, Family 0.409 0.444   0.310       
D4.5 Getting Along, Sexual activities 0.350 0.352 0.344         
D5.6 Activities, Doing most important work well 0.877   0.870         
D5.7 Activities, Getting all the work done 0.887   0.870         
D5.5 Activities, Day to day work 0.875   0.864         
D5.8 Activities, Getting work done as quickly … 0.864   0.835 0.325       
D6.5 Participation, Emotionally affected 0.562 0.409 0.507         
D5.3 Activities, Getting all work done  0.874     0.869       
D5.2 Activities, Most important household tasks 0.852     0.847       
D5.1 Activities, Household responsibilities 0.858     0.838       
D5.4 Activities, Household work as quickly  0.821   0.340 0.794       
D6.4 Participation, Time 0.511 0.322   0.512       
D6.8 Participation, Relaxation or pleasure 0.474 0.434   0.468       
D1.1 Understanding, Concentrating for ten minutes 0.666       0.774     
D1.2 Understanding, Remembering important things 0.695 0.329     0.761     
D1.5 Understanding, Understanding what people say 0.569 0.338     0.643     
D1.4 Understanding, Learning a new task 0.565 0.394     0.595     
D1.3 Understanding, Finding solutions to problems 0.592 0.481     0.545     
D3.2 Self Care, Getting dressed 0.679   0.403   0.449 0.435   
D3.1 Self Care, Washing whole body 0.652   0.350   0.441 0.402 0.313
D2.2 Getting Around, Standing up from sitting 0.616         0.730   
D2.5 Getting Around, Walking a long distance 0.647         0.714   
D2.1 Getting Around, 30min standing 0.591         0.710   
D2.3 Getting Around, Moving around inside 0.687       0.326 0.636 0.336
D2.4 Getting Around, Getting out of your home 0.660         0.502 0.472
D3.3 Self Care, Eating 0.610       0.463   0.577
D3.4 Self Care, Staying by yourself 0.521 0.314         0.573
D6.6 Participation, Financial resources 0.490   0.391       0.542
Extraction Method: Principal Component Analysis. Rotation Method: Varimax with Kaiser Normalization. 
Rotation converged in 93 iterations. 
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Referring to internal conditions, the percentage of variance accounted for by the six component 
model is 65.79%.  
Replication of scales: With respect to Understanding and Communicating full replication of sub-
scale is possible, with item 1.3 being a splitter-item. The other items contain high loadings (lar-
ger than 0.637). Four out of five items of the subscale Getting Around yield one factor with items 
of the subscale Self Care. The item 2.1 (“30 min standing”) loads onto that factor as well as onto 
a factor together with items of the domain Participation. As mentioned above, Self Care yields a 
factor with items of the subscale Getting Around; item 3.4 (“staying by yourself”) loads onto a 
different factor with items of the subscale Getting Along with Others. The subscale Getting Along 
with Others replicates one factor, except item 4.5 (“Sexual activities”), which loads onto another 
factor. In analogy to the replication of scales in musculoskeletal conditions, in the domain Activi-
ties, a division between items that are related to a job and items that are related to household 
activities is obtained. Job-related items show very high loadings (0.885 to 0.918) onto one par-
ticular factor. Household-related items load onto a different factor. Items of the field Participation 
constitute one factor, but also containing splitter-items, that load onto the factors Getting 
Around, Activities and Getting Along with Others. 
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Table 11: Rotated Component Matrix, Internal Conditions 
  h2 1 2 3 4 5 6 
D3.2 Self care, Getting dressed 0.765 0.806           
D2.3 Getting Around, Moving around inside 0.762 0.785           
D3.1 Self Care, Washing whole body 0.764 0.748         0.346
D3.3 Self Care, Eating 0.716 0.699   0.344       
D2.4 Getting Around, Getting out of your home 0.627 0.694           
D2.2 Getting Around, Standing up from sitting 0.536 0.641           
D2.5 Getting Around, Walking a long distance 0.583 0.512 0.395   0.378     
D5.7 Activities, Getting all the work done 0.944   0.918         
D5.5 Activities, Day to day work 0.895   0.908         
D5.6 Activities, Doing most important work well 0.915   0.894         
D5.8 Activities, Getting work done as quickly … 0.909   0.885         
D4.2 Getting Along, Maintaining a friendship 0.691     0.778       
D4.1 Getting Along, Dealing with people you don't know 0.658     0.751       
D4.3 Getting Along, People you are close to 0.649     0.716       
D4.4 Getting Along, Making new friends 0.625     0.665     0.323
D3.4 Self Care, Staying by yourself 0.472     0.600       
D4.5 Getting Along, Sexual activities 0.506       0.638     
D6.5 Participation, Emotionally affected 0.575     0.347 0.605     
D6.2 Participation, Barriers or hindrances 0.658 0.309   0.438 0.584     
D2.1 Getting Around, 30min standing 0.651 0.517 0.327   0.521     
D6.4 Participation, Time 0.541 0.339     0.513     
D6.8 Participation, relaxation or pleasure 0.532   0.334   0.502     
D6.3 Participation, Living with dignity 0.568 0.373   0.381 0.491     
D6.1 Participation, Joining in community activities 0.602   0.412 0.344 0.470     
D6.6 Participation, Financial resources 0.402       0.464     
D6.7 Participation, Family 0.405   0.368   0.417     
D1.1 Understanding, Concentrating for ten minutes 0.634         0.758   
D1.2 Understanding, Remembering important things 0.634         0.747   
D1.5 Understanding, Understanding what people say 0.630         0.711   
D1.6 Understanding, Starting conversation 0.591     0.302   0.678   
D1.4 Understanding, Learning a new task 0.561 0.314       0.637   
D1.3 Understanding, Finding solutions to problems 0.514     0.307 0.312 0.498   
D5.1 Activities, Household responsibilities 0.822 0.346         0.715
D5.3 Activities, Getting all work done that you needed.. 0.816 0.344 0.314   0.312   0.690
D5.2 Activities, Most important household tasks 0.784 0.389 0.330       0.670
D5.4 Activities, Household work as quickly as needed  0.730 0.36 0.371   0.321   0.585
Extraction Method: Principal Component Analysis. Rotation Method: Varimax with Kaiser Normalization. 
Rotation converged in 7 iterations. 
 
In summary the factor analyses of the subgroups musculoskeletal conditions and internal condi-
tions show a satisfactory replication of subscales. Convergent validity was obtained because 
almost all items load strongly on their associated factors (loadings larger than .50) and most of 
the items load stronger on their associated factors rather than on any other factors (24). In a suc-
cessful factor analysis, a few factors should explain a substantial proportion of the variance and 
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the remaining factors explain relatively small amounts of variance, which is the case in these 
results. Even though there is no absolute threshold that can be adopted, a combination of fac-
tors that accounts for 60% of the total variance is deemed satisfactory (7). Based on these find-
ings, it can be concluded that the six factors are suitable to investigate disability and functioning. 
The variance accounted for confirms the multidimensionality of the construct portrayed by the 
questionnaire, whereas, one third of the variance remains unexplained, which indicates that 
there are aspects of disability and functioning that are not being covered by the factors identified 
here. 
 
♦ Inter-Scale Correlations 
For further testing of the dimensionality of WHODAS II, correlations of the subscales and the 
Total Score were examined by means of Pearson correlation coefficient (Table 12). Almost all 
subscales correlate strongly. The Total Score shows highest correlations with the domains Ac-
tivities and Participations, except for the subgroup stroke, which obtains highest correlations 
with the subscales Activities and Getting Around. Low correlations are found between Under-
standing and Activities for musculoskeletal conditions, Getting Around and Getting Along for 
internal conditions and Getting Along and Self Care for breast cancer and depression. 
 
Table 12: Inter-Scale Correlations (Pearson’s Correlation Coefficients) 
Musculoskeletal Conditions           
  Under- standing 
Getting
Around Self Care
Getting
Along Activities
Parti- 
cipation 
Total 
Score 
Understanding 1 0.366** 0.451** 0.578** 0.214** 0.443** 0.610**
Getting Around 0.366** 1 0.593** 0.274** 0.626** 0.587** 0.775**
Self Care 0.451** 0.593** 1 0.423** 0.544** 0.523** 0.722**
Getting Along  0.578** 0.274** 0.423** 1 0.278** 0.488** 0.596**
Activities  0.214** 0.626** 0.544** 0.278** 1 0.668** 0.836**
Participation 0.443** 0.587** 0.523** 0.488** 0.668** 1 0.850**
Total Score 0.610** 0.775** 0.722** 0.596** 0.836** 0.850** 1 
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Table 12 cont.    
Internal Conditions           
  Under- standing 
Getting
Around Self Care
Getting
Along Activities
Parti- 
cipation 
Total 
Score 
Understanding 1 0.468** 0.492** 0.590** 0.470** 0.524** 0.729**
Getting Around 0.468** 1 0.629** 0.390** 0.661** 0.617** 0.792**
Self Care 0.492** 0.629** 1 0.498** 0.587** 0.510** 0.726**
Getting Along  0.590** 0.390** 0.498** 1 0.472** 0.522** 0.706**
Activities  0.470** 0.661** 0.587** 0.472** 1 0.645** 0.869**
Participation 0.524** 0.617* 0.510** 0.522** 0.645** 1 0.849**
Total Score 0.729** 0.792** 0.726** 0.706** 0.869** 0.849** 1 
Stroke             
  Under- standing 
Getting
Around Self Care
Getting
Along Activities
Parti- 
cipation 
Total 
Score 
Understanding 1 0.536** 0.552** 0.713** 0.528** 0.513** 0.742**
Getting Around 0.536** 1 0.788** 0.495** 0.782** 0.660** 0.881**
Self Care 0.552** 0.788** 1 0.592** 0.726** 0.588** 0.856**
Getting Along  0.713** 0.495** 0.592** 1 0.493** 0.492** 0.729**
Activities  0.528** 0.782** 0.726** 0.493** 1 0.766** 0.907**
Participation 0.513** 0.660** 0.588** 0.492** 0.766** 1 0.850**
Total Score 0.742** 0.881** 0.856** 0.729** 0.907** 0.850** 1 
Breast Cancer             
  Under- standing 
Getting
Around Self Care
Getting
Along Activities
Parti- 
cipation 
Total 
Score 
Understanding 1 0.614** 0.491** 0.635** 0.561** 0.545** 0.776**
Getting Around 0.614** 1 0.596** 0.527** 0.711** 0.650** 0.836**
Self Care 0.491** 0.596** 1 0.437** 0.535** 0.502** 0.669**
Getting Along  0.635** 0.527** 0.437** 1 0.522** 0.715** 0.766**
Activities  0.561** 0.711** 0.535** 0.522** 1 0.696** 0.896**
Participation 0.545** 0.650** 0.502** 0.715** 0.696** 1 0.866**
Total Score 0.778** 0.836** 0.669** 0.766** 0.896** 0.866** 1 
Depression             
  Under- standing 
Getting
Around Self Care
Getting
Along Activities
Parti- 
cipation 
Total 
Score 
Understanding 1 0.544** 0.565** 0.640** 0.587** 0.470** 0.771**
Getting Around 0.544** 1 0.722** 0.518** 0.561** 0.677* 0.808**
Self Care 0.565** 0.722** 1 0.429** 0.627** 0.519** 0.757**
Getting Along  0.640** 0.518** 0.429** 1 0.532** 0.676** 0.776**
Activities  0.587** 0.561** 0.627** 0.532** 1 0.749** 0.868**
Participation 0.470** 0.677** 0.519** 0.676** 0.749** 1 0.870**
Total Score 0.771** 0.808** 0.757** 0.776** 0.868** 0.870** 1 
** The correlation is significant on a level of 0.01 (two-tailed). 
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♦ Validity 
Convergent Validity 
For the assessment of convergent validity (as in the sensitivity to change analyses), the sub-
scales of the instruments were organized into dimensions of impairment, activity limitations and 
participation according to Chwastiak et al. (25) (Table 13). It is hypothesized that subscales of the 
WHODAS II and the SF-36, which produce strong correlations reflect the same ICF dimensions. 
Table 13: Organization of Subscales 
SF-36 Mental Health 
SF-36 Vitality 
Impairment 
SF-36 Pain 
SF-36 Physical Functioning 
WHODAS II - Understanding and Communicating 
WHODAS II - Getting Around 
Activity Limitations 
WHODAS II - Self Care 
SF-36 Role Functioning-Physical 
SF-36 Role Functioning-Emotional 
SF-36 Social Functioning 
WHODAS II - Interpersonal 
WHODAS II - Activities 
Participation 
WHODAS II - Participation 
 
Results of convergent validity testing are displayed in Tables 14 to 18. Negative correlations 
between the WHODAS II and the SF-36 reflect the scoring of the instruments: a higher score on 
the WHODAS II means greater functional impairment, a higher SF-36 score reflects better func-
tioning. The WHODAS II subscale Getting Around is highly correlated with SF-36 Physical Func-
tioning subscale (correlations of -0.68 to -0.79). The Participation subscale of the WHODAS II is 
adequately correlated with the Social Functioning subscale of the SF-36 (r = -0.51 to –0.69). 
Similar results are obtained for scales that reflect participation as well, that is Activities and Role 
Functioning-Physical (-0.56 musculoskeletal conditions, -0.52 for internal conditions, -0.67 for 
stroke, -0.70 for breast cancer). In patients with depression, the scale Activities is connected 
with Role Functioning-Emotional more than Role Functioning-Physical. Correlations around 0.5 
are obtained for the scales Activities (WHODAS II) and Social Functioning (SF-36). The SF-36 
subscale Role-Functioning Emotional shows low correlations with the WHODAS II scales in 
most cases. An exception is the breast cancer and depression sample, which show higher cor-
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relations. The Activities subscale is moderately correlated with the Role Functioning-Emotional 
subscale of the SF-36. Depending on the condition group, the WHODAS II Total Score shows 
highest correlations with the SF-36 subscales Physical Functioning (musculoskeletal conditions, 
stroke), with Social Functioning (internal conditions) and with Vitality (breast cancer and depres-
sion). 
 
Table 14: Convergent Validity, Musculoskeletal Conditions 
  
Under-
standing
Getting 
Around 
Self 
Care 
Inter-
personal Activities 
Partici-
pation 
Total  
Score 
Impairment 
SF-36 Mental Health -0.377** -0.183** -0.327** -0.398** -0.306** -0.462** -0.430** 
SF-36 Vitality -0.313** -0.363** -0.285** -0.300** -0.447** -0.506** -0.498** 
SF-36 Pain -0.140* -0.571** -0.334** -0.073 -0.569** -0.473** -0.534** 
Activity Limitations 
SF-36 Physical Functioning -0.226** -0.785** -0.482** -0.129* -0.592** -0.480** -0.619** 
Participation 
SF-36 Role Physical -0.105 -0.499** -0.300** -0.071 -0.559** -0.405** -0.488** 
SF-36 Role Emotional -0.357** -0.295** -0.310** -0.307** -0.247* -0.367** -0.393** 
SF-36 Social Functioning -0.384** -0.414** -0.390** -0.466** -0.466** -0.634** -0.603** 
Composite 
SF-36 mcs -0.454** -0.104 -0.279** -0.470** -0.198** -0.442** -0.398** 
SF-36 pcs -0.048 -0.687** -0.354** -0.190 -0.638** -0.403** -0.534** 
* p<0.05, ** p<0.01 
 
Table 15: Convergent Validity, Internal Conditions 
  
Under-
standing
Getting 
Around 
Self 
Care 
Inter-
personal Activities 
Partici-
pation 
Total 
Score 
Impairment 
SF-36 Mental Health -0.542** -0.357** -0.305** -0.427** -0.398** -0.531** -0.562* 
SF-36 Vitality -0.383** -0.477** -0.282** -0.357** -0.514** -0.539** -0.564** 
SF-36 Pain -0.257** -0.520** -0.270** -0.173** -0.395** -0.397** -0.432** 
Activity Limitations 
SF-36 Physical Functioning -0.274** -0.716** -0.379** -0.176** -0.514** -0.497** -0.563** 
Participation 
SF-36 Role Physical -0.217** -0.532** -0.286** -0.186** -0.517** -0.414** -0.492** 
SF-36 Role Emotional -0.415** -0.409** -0.216** -0.353** -0.334** -0.433** -0.464** 
SF-36 Social Functioning -0.424** -0.448** -0.368** -0.497** -0.490** -0.596** -0.609** 
Composite 
SF-36 mcs -0.513** -0.260** -0.219** -0.492** -0.333** -0.502** -0.503** 
SF-36 pcs -0.151* -0.626** -0.305** -0.101 -0.521** -0.404** -0.477** 
p<0.05, ** p<0.01 
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Table 16: Convergent Validity, Stroke 
  
Under-
standing
Getting 
Around 
Self 
Care 
Inter-
personal Work 
Partici-
pation 
Total 
Score 
Impairment 
SF-36 Mental Health -0.429** -0.387** -0.377** -0.253* -0.454** -0.530** -0.521** 
SF-36 Vitality -0.423** -0.440** -0.427** -0.323** -0.573** -0.571** -0.616** 
SF-36 Pain -0.450** -0.343** -0.248** -0.291** -0.264** -0.301** -0.395** 
Activity Limitations 
SF-36 Physical Functioning -0.404** -0.749** -0.618** -0.368** -0.566** -0.538** -0.666** 
Participation 
SF-36 Role Physical -0.477** -0.411** -0.297** -0.304** -0.665** -0.506** -0.623** 
SF-36 Role Emotional -0.382** -0.379** -0.306** -0.299** -0.483** -0.472** -0.505** 
SF-36 Social Functioning -0.432** -0.355** -0.254** -0.437** -0.510** -0.511** -0.555** 
Composite 
SF-36 mcs -0.403** -0.269* -0.244* -0.366** -0.491** -0.550** -0.504** 
SF-36 pcs -0.485** -0.636** -0.487** -0.417** -0.528** -0.484** -0.621** 
* p<0.05, ** p<0.01 
 
Table 17: Convergent Validity, Breast Cancer 
  
Under-
standing
Getting 
Around 
Self 
Care 
Inter-
personal Activities 
Partici-
pation 
Total 
 Score 
Impairment 
SF-36 Mental Health -0.541** -0.530** -0.385** -0.520** -0.566** -0.644** -0.682** 
SF-36 Vitality -0.488** -0.548** -0.345** -0.438** -0.752** -0.589** -0.718** 
SF-36 Pain -0.311** -0.438** -0.195* -0.263** -0.488** -0.348** -0.457** 
Activity Limitations 
SF-36 Physical Functioning -0.449** -0.784** -0.373** -0.360** -0.715** -0.504** -0.688** 
Participation 
SF-36 Role Functioning -0.370** -0.483** -0.373** -0.343** -0.701** -0.465** -0.621** 
SF-36 Role Emotional -0.625** -0.484** -0.380** -0.485** -0.556** -0.611** -0.659** 
SF-36 Social Functioning -0.453** -0.512** -0.380** -0.521** -0.603** -0.689** -0.678** 
Composite 
SF-36 mcs -0.629** -0.471** -0.407** -0.563** -0.546** -0.675** -0.683** 
SF-36 pcs -0.315** -0.632** -0.331** -0.266** -0.636** -0.362** -0.554** 
* p<0.05, ** p<0.01 
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Table 18: Convergent Validity, Depression 
  
Under-
standing
Getting 
Around 
Self 
Care 
Inter-
personal Activities 
Partici-
pation 
Total 
 Score 
Impairment 
SF-36 Mental Health -0.566** -0.307* -0.271* -0.515** -0.446** -0.424** -0.531** 
SF-36 Vitality -0.426** -0.499** -0.476** -0.464** -0.532** -0.556** -0.608** 
SF-36 Pain -0.268* -0.431** -0.298* -0.339** -0.375** -0.455** -0.454** 
Activity Limitations 
SF-36 Physical Functioning -0.346** -0.678** -0.485** -0.346** -0.369** -0.498** -0.549** 
Participation 
SF-36 Role Physical -0.336** -0.539** -0.385** -0.352** -0.379** -0.495** -0.513** 
SF-36 Role Emotional -0.404** -0.314* -0.250* -.361** -0.480** -0.429** -0.485** 
SF-36 Social Functioning -0.347** -0.400** -0.200 -0.535** -0.558** -0.689** -0.595** 
Composite 
SF-36 mcs -0.461** -0.133 -0.127 -0.464** -0.481** -0.418** -0.458** 
SF-36 pcs -0.258* -0.646** -0.434** -0.324* -0.337** -0.512** -0.510** 
* p<0.05, ** p<0.01 
Discriminant Validity 
One purpose of the discriminant analysis was to investigate independent variable mean differ-
ences between groups formed by the dependent variable. For musculoskeletal diseases, highly 
significant mean differences between groups (no/mild pain, N=91 vs. strong pain, N=73) exist 
regarding the following subscales: Getting Around**, Self Care**, Activity** and Participation**. 
In the subgroup internal conditions (no/mild pain, N=238 vs. moderate to strong pain, N=45) 
Wilk's Lambda is significant by the F-Test for the subscales Getting Around** and Activities**. 
Patients in the group stroke (no/mild pain, N=87 vs. moderate to strong pain, N=11) show sig-
nificant differences in the scale Activities**, patients in the group breast cancer (no/mild pain, 
N=81 vs. moderate to strong pain, N=35) in the scales Understanding*, Getting Around**, Get-
ting Along with Others*, Activities* and Participation **, patients with depression (no/mild pain, 
N=37 vs. strong pain, N=12) in the scales Getting Around**, Self Care* and Participation* (* 
p<0.05, **p<0.01). Squared canonical correlation is the percent of variation in the dependent 
explained by the independents. In musculoskeletal conditions, internal conditions, breast cancer 
and depression the eigenvalue of the discriminant function is significant (Table 19). For patients 
with musculoskeletal conditions, 17.22% of the variation in the dependent variable is discrimi-
nated by the independent variables (internal conditions: 8.41%, breast cancer: 19.18%, depres-
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sion: 36.48%). The variance explained by the SF-36 is distinctly higher (musculoskeletal condi-
tions: 21.44%, internal conditions: 15.21%, breast cancer: 39.81% and depression: 39.19%, 
respectively), resulting from the fact, that the SF-36 possesses a scale that measures bodily 
pain directly. In this study, severity of disease is operationalized by the value of Sensation of 
Pain. 
 
Table 19: Discriminant Validity 
Discriminant Validity 
Musculoskeletal Conditions 
WHODAS II 
(no/mild pain, N=91 vs. strong pain, N=73)   
Canonical correlation coefficient 0.415 
Wilks Lambda 0.828** 
SF-36 
(no/mild pain, N=87 vs. strong pain, N=69) 
Canonical correlation coefficient 0.463 
Wilks Lambda 0.786 ** 
Internal Conditions 
WHODAS II 
(no/mild pain, N=238 vs. moderate to strong pain, N=45)   
Canonical correlation coefficient 0.290 
Wilks Lambda 0.915** 
SF-36 
(no/mild pain, N=226 vs. moderate to strong pain, N=44) 
Canonical correlation coefficient 0.390 
Wilk's Lambda 0.852** 
Stroke 
WHODAS II 
(no/mild pain, N=87 vs. moderate to strong pain, N=11)   
Canonical correlation coefficient 0.242 
Wilk's Lambda 0.942(ns.) 
SF-36 
(no/mild pain, N=70 vs. moderate to strong pain, N=9) 
Canonical correlation coefficient 0.432 
Wilk's Lambda 0.813 (n.s.) 
Breast Cancer 
WHODAS II 
(no/mild pain, N=81 vs. moderate to strong pain, N=35)   
Canonical correlation coefficient 0.438 
Wilk's Lambda 0.808** 
SF-36 
(no/mild pain, N=76 vs. moderate to strong pain, N=34) 
Canonical correlation coefficient 0.631 
Wilk's Lambda 0.602** 
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Table 19 cont.  
Depression 
WHODAS II 
(no/mild pain, N=37 vs. strong pain, N=12)   
Canonical correlation coefficient 0.604 
Wilk's Lambda 0.635** 
SF-36 
(no/mild pain, N=37 vs. strong pain, N=11) 
Canonical correlation coefficient 0.626 
Wilk's Lambda 0.609** 
p<0.05, ** p<0.01 
 
The standardized discriminant function coefficients indicate the relative importance of the inde-
pendent variable in the predicting the dependent. In musculoskeletal conditions the subscales 
Getting Around and Activities are the most important variables (standardized discriminant func-
tion coefficients: 0.720 and 0.514), in internal conditions and breast cancer the scale Getting 
Around is the most important variable as well. In the depression sample Participation is the most 
explaining variable. Regarding the SF-36 the most important variables are Bodily Pain or Physi-
cal Functioning in all subgroups. Finally the theory (discriminant function) was tested by observ-
ing whether cases are classified as predicted (Table 20). In the subgroup musculoskeletal condi-
tions the discriminant function correctly classifies about 67% of the cases predicting strong pain, 
no/mild pain was classified correctly in 83.5% of the cases, making more proportion of mistakes 
in the category strong pain. Regarding internal conditions the model correctly classifies 98.3% in 
the category no/mild pain and only 4.4% in the category moderate to strong pain. In breast can-
cer 90.1% of the cases in the category no/mild pain are classified correctly and 37.1% in the 
category moderate to strong pain. In the subgroup depression 91.9% of the cases in the cate-
gory no/mild pain are classified correctly and 66.7% in the category strong pain. The classifica-
tion by means of the SF-36 leads to comparable (to slightly better) results (Table 20). 
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Table 20: Discriminant Function: Classification Results 
Musculoskeletal Conditions 
WHODAS II 
Predicted 
Membership      
no/mild pain strong pain Total 
no/mild pain (N=91) 83.52 16.48 100.00 
strong pain (N=73) 32.88 67.12 100.00 
Original 
% 
ungrouped (N=121) 61.98 38.02 100.00 
76,2% of original grouped cases correctly classified.     
SF-36 
Predicted 
Membership      
no/mild pain strong pain Total 
no/mild pain (N=87) 82.76 17.24 100.00 
strong pain (N=69) 17.39 82.61 100.00 
Original 
% 
ungrouped (N=124) 57.26 42.74 100.00 
82,7% of original grouped cases correctly classified.     
Internal Conditions 
WHODAS II 
Predicted 
Membership      
no/mild pain moderate to strong pain Total 
no/mild pain (N=238) 98.32 1.68 100.00 
moderate to strong pain (N=45) 95.56 4.44 100.00 
Original 
% 
ungrouped (N=3) 100.00 0.00 100.00 
83,4% of original grouped cases correctly classified.     
SF-36 
Predicted 
Membership      
no/mild pain moderate to strong pain Total 
no/mild pain (N=87) 97.35 2.65 100.00 
moderate to strong pain (N=69) 90.91 9.09 100.00 
Original 
% 
ungrouped (N=3) 100.00 0.00 100.00 
83% of original grouped cases correctly classified.     
Breast Cancer 
WHODAS II 
Predicted 
Membership      
no/mild pain moderate to strong pain Total 
no/mild pain (N=91) 90.12 9.88 100.00 
moderate to strong pain (N=73) 62.86 37.14 100.00 
Original 
% 
ungrouped (N=1) 100.00 0.00 100.00 
74,1% of original grouped cases correctly classified.     
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Table 20 cont.   
SF-36 
Predicted 
Membership      
no/mild pain moderate to strong pain Total 
no/mild pain (N=87) 89.47 10.53 100.00 
moderate to strong pain (N=69) 38.24 61.76 100.00 
Original 
% 
ungrouped (N=1) 100.00 0.00 100.00 
80,9% of original grouped cases correctly classified.     
Depression 
WHODAS II 
Predicted 
Membership      
no/mild pain strong pain Total 
no/mild pain (N=91) 91.89 8.11 100.00 
strong pain (N=73) 33.33 66.67 100.00 
Original 
% 
ungrouped (N=15) 93.33 6.67 100.00 
85,7% of original grouped cases correctly classified.     
SF-36 
Predicted 
Membership      
no/mild pain strong pain Total 
no/mild pain (N=87) 89.19 10.81 100.00 
strong pain (N=69) 36.36 63.64 100.00 
Original 
% 
ungrouped (N=14) 92.86 7.14 100.00 
83,3% of original grouped cases correctly classified.     
 
♦ Sensitivity to Change 
To examine differences between baseline and follow-up t-test for paired samples was per-
formed. If this test yields significant mean differences, a certain sensitivity to change of the scale 
can be assumed (26). As inference-statistical methods are not sufficient - the result of a test of 
significance is dependent on the sample size (27) - sensitivity of each subscale of the WHODAS 
II and the SF-36 from baseline to follow-up was evaluated by the effect size and the standard-
ized response mean (Table 21). Among the Total Scores of the WHODAS II and the SF-36, in 
the musculoskeletal conditions subgroup the SF-36 Physical Health Index Score shows the 
highest sensitivity from baseline to follow-up, in internal conditions and stroke the WHODAS II 
Total Score, and in breast cancer and depression the SF-36 Mental Health Index Score. The 
depression sample produces the highest sensitivity over all subscales of the WHODAS II. The 
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calculation of SRM generally yielded somewhat smaller numbers but did not change the inter-
pretation of the data.  
Table 21: Sensitivity to Change 
Musculoskeletal Conditions           
  
WHODAS II 
T1 
mean 
T1 
SD 
T2 
mean 
T2 
SD 
Effect 
Size SRM 
Understanding/Communicating* 17.52 17.55 14.69 17.25 -0.16 -0.16 
Getting Around* 29.64 21.78 23.34 21.41 -0.29 -0.29 
Self Care 8.72 15.10 7.10 14.91 -0.11 -0.11 
Getting Along with Others 12.43 15.21 11.23 15.44 -0.08 -0.08 
Activities* 33.12 24.96 24.09 25.82 -0.36 -0.35 
Participation* 23.51 17.32 19.18 19.28 -0.25 -0.22 
Total Score* 21.98 14.32 17.33 16.10 -0.32 -0.29 
SF-36 
T1 
mean 
T1 
SD 
T2 
mean 
T2 
SD 
Effect 
Size SRM 
Physical Functioning* 59.59 25.41 65.09 27.48 0.22 0.20 
Role Functioning-Physical* 33.28 38.24 48.54 42.51 0.40 0.36 
Bodily Pain* 35.27 19.43 48.84 21.96 0.70 0.62 
General Health* 49.39 17.63 55.02 18.88 0.32 0.30 
Vitality* 43.01 17.99 53.19 20.17 0.57 0.50 
Social Functioning* 71.13 25.81 76.73 26.08 0.22 0.21 
Role Functioning-Emotional 74.45 39.59 74.16 40.08 -0.01 -0.01 
Mental Health* 62.60 19.61 69.20 19.33 0.34 0.34 
PHYSICAL HEALTH INDEX SCORE* 34.12 9.96 38.52 10.58 0.44 0.42 
MENTAL HEALTH INDEX SCORE* 48.45 11.47 50.41 10.87 0.17 0.18 
 
Internal Conditions           
  
WHODAS II 
T1 
mean 
T1 
SD 
T2 
mean 
T2 
SD 
Effect 
Size SRM 
Understanding/Communicating* 18.81 17.78 14.14 16.11 -0.26 -0.29 
Getting Around* 19.51 20.38 14.85 17.97 -0.23 -0.26 
Self Care* 6.47 14.97 4.27 10.73 -0.15 -0.20 
Getting Along with Others* 13.93 16.58 11.65 15.75 -0.14 -0.15 
Activities* 22.73 24.27 18.20 22.54 -0.19 -0.20 
Participation* 23.15 19.36 18.97 17.11 -0.22 -0.24 
Total Score* 18.47 15.32 14.65 13.64 -0.25 -0.28 
SF-36 
T1 
mean 
T1 
SD 
T2 
mean 
T2 
SD 
Effect 
Size SRM 
Physical Functioning* 66.01 27.59 72.33 25.91 0.23 0.24 
Role Functioning-Physical* 49.09 43.08 56.64 43.71 0.18 0.17 
Bodily Pain* 59.17 31.15 66.11 28.43 0.22 0.24 
General Health* 50.12 19.77 55.65 20.61 0.28 0.27 
Vitality* 48.64 20.57 58.21 19.30 0.47 0.50 
Social Functioning* 73.27 26.21 78.45 24.78 0.20 0.21 
Role Functioning-Emotional 73.45 39.96 75.09 38.32 0.04 0.04 
Mental Health* 64.91 20.58 70.69 18.75 0.28 0.31 
PHYSICAL HEALTH INDEX SCORE* 40.62 11.37 42.88 11.03 0.20 0.20 
MENTAL HEALTH INDEX SCORE* 47.47 11.60 49.80 10.52 0.20 0.22 
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Stroke            
  
WHODAS II 
T1 
mean 
T1 
SD 
T2 
mean 
T2 
SD 
Effect 
Size SRM 
Understanding/Communicating 31.26 23.79 35.96 24.41 0.20 0.19 
Getting Around 42.20 34.58 41.88 33.55 -0.01 -0.01 
Self Care 30.58 31.90 29.62 32.38 -0.03 -0.03 
Getting Along with Others* 24.60 24.39 28.93 24.19 0.18 0.18 
Activities 53.24 35.39 57.97 33.77 0.13 0.14 
Participation 41.18 25.31 43.68 24.28 0.10 0.10 
Total Score 38.72 24.79 42.76 24.69 0.16 0.16 
SF-36 
T1 
mean 
T1 
SD 
T2 
mean 
T2 
SD 
Effect 
Size SRM 
Physical Functioning 43.67 33.90 48.55 34.09 0.14 0.14 
Role Functioning-Physical 22.66 37.71 20.00 32.50 -0.07 -0.08 
Bodily Pain 58.06 31.79 56.40 31.03 -0.05 -0.05 
General Health 45.69 20.10 43.08 20.20 -0.13 -0.13 
Vitality 38.92 23.37 42.44 19.80 0.15 0.18 
Social Functioning 60.51 27.96 58.76 28.59 -0.06 -0.06 
Role Functioning-Emotional 46.30 46.79 40.82 44.88 -0.12 -0.12 
Mental Health 55.44 21.72 56.86 19.12 0.07 0.07 
PHYSICAL HEALTH INDEX SCORE 35.15 10.20 35.41 10.81 0.03 0.02 
MENTAL HEALTH INDEX SCORE 42.06 12.06 41.32 10.77 -0.06 -0.07 
 
Breast Cancer           
  
WHODAS II 
T1 
mean 
T1 
SD 
T2 
mean 
T2 
SD 
Effect 
Size SRM 
Understanding/Communicating* 23.80 18.79 19.77 18.55 -0.21 -0.22 
Getting Around* 19.48 18.99 15.76 18.77 -0.20 -0.20 
Self Care*   7.42 13.23   4.57 9.56 -0.21 -0.30 
Getting Along with Others* 18.65 17.33 15.56 16.57 -0.18 -0.19 
Activities* 34.33 27.30 28.25 26.36 -0.22 -0.23 
Participation* 27.75 19.39 24.03 18.36 -0.19 -0.20 
Total Score* 23.84 16.61 20.03 16.05 -0.23 -0.24 
SF-36 
T1 
mean 
T1 
SD 
T2 
mean 
T2 
SD 
Effect 
Size SRM 
Physical Functioning* 67.19 23.10 72.34 20.38 0.22 0.25 
Role Functioning-Physical* 38.60 38.71 45.23 38.83 0.17 0.17 
Bodily Pain* 59.84 27.45 66.75 25.57 0.25 0.27 
General Health 56.55 18.89 58.38 18.12 0.10 0.10 
Vitality* 44.52 22.27 55.34 20.18 0.49 0.54 
Social Functioning* 70.44 27.13 78.13 25.90 0.28 0.30 
Role Functioning-Emotional 62.57 44.60 61.86 44.23 -0.02 -0.02 
Mental Health* 60.86 20.73 69.46 20.42 0.41 0.42 
PHYSICAL HEALTH INDEX SCORE* 40.92 10.24 42.83 8.71 0.19 0.22 
MENTAL HEALTH INDEX SCORE* 44.33 12.64 47.49 12.28 0.25 0.26 
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Depression           
  
WHODAS II 
T1 
mean 
T1 
SD 
T2 
mean 
T2 
SD 
Effect 
Size SRM 
Understanding/Communicating* 48.17 21.36 36.16 21.16 -0.56 -0.57 
Getting Around* 30.22 26.70 22.50 25.46 -0.29 -0.30 
Self Care* 16.44 20.15 10.60 15.35 -0.29 -0.38 
Getting Along with Others* 44.58 25.43 31.91 21.94 -0.50 -0.58 
Activities* 54.26 25.58 37.16 28.66 -0.67 -0.60 
Participation* 54.46 19.79 39.64 21.57 -0.75 -0.69 
Total Score* 44.56 18.95 31.55 19.17 -0.69 -0.68 
SF-36 
T1 
mean 
T1 
SD 
T2 
mean 
T2 
SD 
Effect 
Size SRM 
Physical Functioning* 65.75 28.11 74.74 27.93 0.32 0.32 
Role Functioning-Physical* 37.90 39.66 54.02 40.39 0.41 0.40 
Bodily Pain* 40.94 32.60 54.52 30.18 0.42 0.45 
General Health* 39.11 19.21 52.05 21.73 0.67 0.60 
Vitality* 21.69 12.48 43.48 21.31 1.75 1.02 
Social Functioning* 31.54 22.00 53.13 23.63 0.98 0.91 
Role Functioning-Emotional* 17.71 30.27 44.24 41.10 0.88 0.65 
Mental Health* 31.18 16.90 52.00 20.41 1.23 1.02 
PHYSICAL HEALTH INDEX SCORE* 41.86 11.86 45.23 11.06 0.28 0.30 
MENTAL HEALTH INDEX SCORE* 24.42 8.57 36.37 11.93 1.39 1.00 
Difference mean t1, t2 by t-Test: * p<0.05, ** p<0.01 
As sensitivity to change is the consequence of interaction between treatment, scale and popula-
tion (28), we analyzed the effect sizes for patients who assessed their perceived general health 
status better than before the rehabilitation treatment. Improvement was defined as a better 
score in item 1 (general health) of the SF-36 (Table 22). With only a few exceptions (e.g. for 
stroke: Getting Along with Others), effect size and SRM are larger when only patients who re-
ported an improvement in general health had been selected. 
Among the Total Scores of the WHODAS II and the SF-36, for the musculoskeletal and internal 
conditions, the SF-36 Physical Health Index Score shows the highest sensitivity from baseline to 
follow-up, in stroke and breast cancer the WHODAS II Total Score, and in depression the SF-36 
Mental Health Index Score. All in all, moderate to large effect sizes are obtained. Especially in 
the subgroup depression effect sizes are large (WHODAS II Total Score: -0.915). In this sub-
group, larger changes are shown by the Mental Health Index Score (2.023) than by the Physical 
Health Index Score (0.467) of the SF-36. 
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Among the six domains of the WHODAS II, the responsiveness indices on the scale Activities 
are the highest for musculoskeletal conditions and breast cancer, respectively the scale Self 
Care for stroke, Getting Around for internal conditions and Participation for depression. 
 
Table 22: Sensitivity to Change – Improvement Concerning the Item General Health (SF-36) 
Musculoskeletal Conditions           
  
WHODAS II 
T1 
mean 
T1 
SD 
T2 
mean 
T2 
SD 
Effect 
Size SRM 
Understanding/Communicating* 15.58 17.23 12.46 14.58 -0.18 -0.21 
Getting Around* 27.84 19.85 19.18 20.46 -0.44 -0.42 
Self Care* 6.63 10.83 4.73 10.46 -0.18 -0.18 
Getting Along with Others* 11.55 15.00 9.15 12.67 -0.16 -0.19 
Activities* 35.17 24.96 20.72 23.59 -0.58 -0.61 
Participation* 23.01 16.95 15.98 16.50 -0.41 -0.43 
Total Score* 21.44 13.55 14.51 13.87 -0.51 -0.50 
SF-36 
T1 
mean 
T1 
SD 
T2 
mean 
T2 
SD 
Effect 
Size SRM 
Physical Functioning* 62.51 23.16 70.81 27.64 0.36 0.30 
Role Functioning-Physical* 29.17 37.17 56.80 41.58 0.74 0.66 
Bodily Pain* 32.99 18.29 55.55 21.10 1.23 1.07 
General Health* 47.58 16.09 60.28 17.22 0.79 0.74 
Vitality* 41.93 16.22 55.88 18.63 0.86 0.75 
Social Functioning* 71.85 27.40 80.11 23.81 0.30 0.35 
Role Functioning-Emotional 77.49 38.02 78.36 37.36 0.02 0.02 
Mental Health* 62.22 18.84 70.13 17.35 0.42 0.46 
PHYSICAL HEALTH INDEX SCORE* 33.56 8.98 41.60 9.76 0.90 0.82 
MENTAL HEALTH INDEX SCORE* 48.71 10.67 50.48 9.78 0.17 0.18 
 
Internal Conditions           
  
WHODAS II 
T1 
mean 
T1 
SD 
T2 
mean 
T2 
SD 
Effect 
Size SRM 
Understanding/Communicating* 20.45 17.37 14.88 17.46 -0.32 -0.32 
Getting Around* 18.91 18.41 12.76 17.80 -0.33 -0.35 
Self Care 7.68 16.40 5.69 12.31 -0.12 -0.16 
Getting Along with Others* 15.12 16.75 12.20 16.17 -0.17 -0.18 
Activities* 25.11 23.73 19.01 24.32 -0.26 -0.25 
Participation* 23.54 18.71 18.66 17.48 -0.26 -0.28 
Total Score* 19.19 14.10 15.26 15.25 -0.28 -0.26 
SF-36 
 T1 
mean 
T1 
SD 
T2 
mean 
T2 
SD 
Effect 
Size SRM 
Physical Functioning* 65.48 25.39 74.58 25.77 0.36 0.35 
Role Functioning-Physical* 46.39 40.98 57.58 45.13 0.27 0.25 
Bodily Pain* 54.25 29.05 66.84 27.13 0.43 0.46 
General Health* 45.57 19.32 58.40 19.39 0.66 0.66 
Vitality* 45.24 17.79 59.50 18.56 0.80 0.77 
Social Functioning* 72.28 26.20 79.58 23.44 0.28 0.31 
Role Functioning-Emotional* 65.53 43.31 74.71 36.99 0.21 0.25 
Mental Health* 62.54 20.26 70.29 18.09 0.38 0.43 
PHYSICAL HEALTH INDEX SCORE* 39.44 10.46 44.07 10.47 0.44 0.44 
MENTAL HEALTH INDEX SCORE* 45.46 11.81 49.56 9.68 0.35 0.42 
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Stroke            
  
WHODAS II 
T1 
mean 
T1 
SD 
T2 
mean 
T2 
SD 
Effect 
Size SRM 
Understanding/Communicating 37.95 20.72 35.00 26.81 -0.14 -0.11 
Getting Around 38.39 29.34 36.00 31.85 -0.08 -0.07 
Self Care* 34.64 27.21 23.00 31.60 -0.43 -0.37 
Getting Along with Others 21.61 16.14 22.39 23.13 0.05 0.03 
Activities* 54.02 29.27 44.70 34.88 -0.32 -0.27 
Participation 40.77 22.06 37.50 23.30 -0.15 -0.14 
Total Score* 40.02 18.76 35.90 24.99 -0.22 -0.17 
SF-36 
T1 
mean 
T1 
SD 
T2 
mean 
T2 
SD 
Effect 
Size SRM 
Physical Functioning 39.27 30.81 48.73 31.49 0.31 0.30 
Role Functioning-Physical* 4.17 12.86 14.77 29.54 0.82 0.36 
Bodily Pain 56.84 32.04 57.20 27.44 0.01 0.01 
General Health* 39.40 16.84 48.12 23.31 0.52 0.37 
Vitality* 35.87 17.75 45.87 19.90 0.56 0.50 
Social Functioning 60.00 27.72 62.50 27.00 0.09 0.09 
Role Functioning-Emotional 35.42 44.67 45.45 47.75 0.22 0.21 
Mental Health* 47.62 18.15 54.61 20.23 0.39 0.35 
PHYSICAL HEALTH INDEX SCORE 34.91 7.88 35.56 9.70 0.08 0.07 
MENTAL HEALTH INDEX SCORE 40.18 9.84 41.02 11.66 0.09 0.07 
 
Breast Cancer           
  
WHODAS II 
T1 
mean 
T1 
SD 
T2 
mean 
T2 
SD 
Effect 
Size SRM 
Understanding/Communicating* 28.47 20.99 18.89 17.05 -0.46 -0.56 
Getting Around* 24.00 18.82 15.17 17.98 -0.47 -0.49 
Self Care* 10.83 16.89 3.75 5.59 -0.42 -1.27 
Getting Along with Others* 23.89 17.62 14.88 15.19 -0.51 -0.59 
Activities* 45.04 25.34 29.35 26.26 -0.62 -0.60 
Participation* 32.10 16.78 22.87 14.02 -0.55 -0.66 
Total Score* 29.74 15.86 18.75 13.16 -0.69 -0.84 
SF-36 
 T1 
mean 
T1 
SD 
T2 
mean 
T2 
SD 
Effect 
Size SRM 
Physical Functioning* 63.72 20.32 75.28 14.78 0.57 0.78 
Role Functioning-Physical* 23.28 34.02 41.38 32.92 0.53 0.55 
Bodily Pain 53.27 28.22 59.53 20.69 0.22 0.30 
General Health* 50.41 17.10 61.30 16.52 0.64 0.66 
Vitality* 37.11 21.40 54.00 18.45 0.79 0.92 
Social Functioning* 61.25 28.49 78.33 24.77 0.60 0.69 
Role Functioning-Emotional 58.33 45.02 66.67 42.72 0.19 0.20 
Mental Health* 56.97 20.09 69.87 17.97 0.64 0.72 
PHYSICAL HEALTH INDEX SCORE* 36.96 9.37 42.21 6.68 0.56 0.79 
MENTAL HEALTH INDEX SCORE* 41.98 13.40 48.56 11.51 0.49 0.57 
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Depression           
  
WHODAS II 
T1 
mean 
T1 
SD 
T2 
mean 
T2 
SD 
Effect 
Size SRM 
Understanding/Communicating* 50.12 23.47 32.11 20.40 -0.77 -0.88 
Getting Around* 30.48 26.92 17.79 22.70 -0.47 -0.56 
Self Care 14.34 22.80 7.17 14.69 -0.31 -0.49 
Getting Along with Others* 49.45 24.52 27.50 20.99 -0.90 -1.05 
Activities* 52.78 27.76 31.97 29.75 -0.75 -0.70 
Participation* 55.32 20.95 36.03 20.99 -0.92 -0.92 
Total Score* 45.41 20.23 26.88 18.49 -0.92 -1.00 
SF-36 
T1 
mean 
T1 
SD 
T2 
mean 
T2 
SD 
Effect 
Size SRM 
Physical Functioning* 65.40 25.86 79.38 25.03 0.54 0.56 
Role Functioning-Physical* 40.63 42.48 58.09 41.16 0.41 0.42 
Bodily Pain* 37.62 32.83 55.38 32.15 0.54 0.55 
General Health* 36.37 14.41 59.00 16.69 1.57 1.36 
Vitality* 22.06 12.44 48.68 20.10 2.14 1.32 
Social Functioning* 28.31 22.26 54.78 24.23 1.19 1.09 
Role Functioning-Emotional* 15.15 28.98 52.53 39.99 1.29 0.93 
Mental Health* 27.65 15.01 54.24 19.38 1.77 1.37 
PHYSICAL HEALTH INDEX SCORE* 41.73 11.49 47.10 9.88 0.47 0.54 
MENTAL HEALTH INDEX SCORE* 22.71 7.65 38.19 11.93 2.02 1.30 
Difference mean t1, t2 by t-Test: * p<0.05, ** p<0.01 
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DISCUSSION 
 
WHODAS II, the generic instrument for measuring disability, functioning and health, which is 
conceptually compatible with the International Classification of Disability, Functioning and Health 
(ICF), has been investigated in patients with musculoskeletal conditions, cardiovascular and 
general internal conditions, stroke, breast cancer and depressive disorder. All subgroups show a 
wide range of diseases, complaints and symptoms. The advantage of this approach is to en-
hance the generalizability of the results (29). 
A wide range in scores on the subscales and the Total Score of WHODAS II is found (0 to 100 
in all subscales and the Total Score). According to van Tubergen et al. (29) stating a submitted 
study (30), as a generic instrument, the WHODAS II would especially be useful for studies de-
signed to compare across different disease entities or interventions, similar to other generic in-
struments such as the SF-36. In contrast to that instrument for health status, the WHODAS II is 
based on an international classification system, it is designed to be applicable across different 
cultures, and it treats all disorders at parity when determining the level of functioning. The physi-
cal, personal and social levels of disability are well represented in the WHODAS II in this study: 
scores on the WHODAS II were significantly correlated with an external criterion, the SF-36. 
The results of a psychometric properties analysis allow statements concerning both the quality 
of the instrument and the sample (31), as the measurement properties of an instrument are rela-
tive concepts, which vary with regard to the sample, the objective of the study, the type of the 
study and the duration (8).  
Quality of Data 
Data quality is an indispensable requirement for meaningful data interpretation. The data set’s 
quality can be evaluated by means of the rate of missing values. In this study relatively few 
missing values are obtained. Missing values can be found most prominently in questions that 
are regarded irrelevant or not applicable, i.e. questions concerning a job in the domain Activities. 
In the data set on which this study is based, missing values do not occur systematically and in 
most variables the missing value rate is below the critical limit of 10%. 
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Floor- and Ceiling Effects 
The subscales of the WHODAS II show partially high floor effects. In the domain Self Care up to 
70.3% of the patients report no impairment (best possible score 0). 
Reliability 
Cronbach's Alpha was estimated for each of the subscales in every sample to measure internal 
consistency. The internal consistency of the scales of WHODAS II is found to be high. All sub-
scales meet the required Cronbach’s alpha equal or greater than 0.7 for group comparisons (7). 
Only the domain Activities would fulfill the level of 0.95 required for use in individual patients 
according to Nunally (21). Methodological issues have to be considered: First, floor and ceiling 
effects bias the results. Secondly, the WHODAS II was not administered twice to a group that 
remained stable over time, i.e. was not expected to show any change over time. Thus, we can-
not draw any conclusions about the reproducibility of the WHODAS II in the tested samples. 
Reproducibility is very important when the instrument is to be applied in longitudinal studies. 
Further studies will be needed to establish reproducibility. According to van Tubergen (29), in ex-
tensive testing that has not yet been published (32), the WHODAS II has been shown to have a 
test-retest reliability ranging from 0.91 to 0.95 (within class correlations) across respondents 
from different geographical regions and from physical disorder. 
Factor Analysis 
By means of a factor analysis we examined to what extent the items can be assigned to their 
scales. All in all, the exploratory factor structure of the German version of the WHODAS II con-
tains high correspondence with the original structure. The Principal Component Analysis shows 
a stable factor structure that is replicable in musculoskeletal and internal conditions, and unidi-
mensionality of domains (loadings greater than 0.5). For the most part, the results of the scale 
replication confirm the determined six domains of the questionnaire. For the domain Activities, a 
clear distinction between work und household activities is apparent in both musculoskeletal and 
internal conditions. Some cross-loadings are obtained, e.g. the mobility item 2.1 (“30 min stand-
ing”) loads onto the mobility factor as well as onto a factor together with items of the domain 
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Participation. This is plausible as regards content, since these areas mutually determine each 
other. 
Inter-Scale Correlations 
In order to further test the dimensionality of WHODAS II, correlations of the subscales and the 
inter-scale correlations by means of Pearson correlation coefficients show strong correlations in 
almost all subscales. Low correlations exist between Understanding and Activities for muscu-
loskeletal conditions, Getting Around and Getting Along for internal conditions and Getting Along 
and Self Care for breast cancer and depression. In this context it has to be taken into considera-
tion whether a summary score makes sense at all. Noticing that the sum score correlates the 
most with Participation and Activities, and that there are few but some low correlation between 
subscales, one has to keep in mind that the sum-scale is leveling the result. It is not apparent 
any more whether the patient has average values in all subscales or extremely high values in 
some and extremely low values in other domains. 
Validity 
The different domains of the WHODAS II show a fair correlation with another well-established 
instrument, the SF-36. As hypothesized, scores that represent the same area (activities limita-
tions, participation) correlate strongly, indicating that both questionnaires measure a similar con-
struct. Consistent with findings of Chwastiak & Von Korff (25), tests of convergent validity of the 
WHODAS II subscales with subscales of the SF-36 that produced strong correlations (i.e., Get-
ting Around and Physical Functioning, Participation and Social Functioning) reflect the same ICF 
dimensions. The SF-36 subscale Role-Functioning Emotional shows low correlations with the 
WHODAS II scales in most cases. This leads to the conclusion that this aspect is not covered by 
the WHODAS II. Exceptions are the breast cancer and depression samples, which show higher 
correlations. The Activities subscale is moderately correlated with the Role Functioning-
Emotional subscale of the SF-36, analogous to findings of Chwastiak & Von Korff (25). 
Ability to differentiate is confirmed by the results of the discriminant analyses, where 83.52% to 
98.32% of cases (no/mild pain) are classified correctly. To assess different specification of dis-
ease, Sensation of Pain is used as a grouping variable. The WHODAS II does not assess bodily 
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pain directly, as opposed to the SF-36. It has to be taken into account that the operationalization 
through the variable pain is critical, as pain must not be an indicator of severity of disease, but 
can derive from concomitant diseases as well.  
Although the activity limitations and participation indices examined in this study are related, they 
are not equivalent, and should not be regarded as interchangeable. 
Sensitivity to Change 
As no test-retest analyses were conducted, we have no information on to what degree the re-
sponsiveness scores of the WHODAS II may be determined by a potential degree of lack of re-
producibility. However, the level of responsiveness was similar to the SF-36 that has been 
shown to be reproducible and responsive (4, 6). 
According to van Tubergen et al. (29) in patient populations with schizophrenia, depression, and 
alcohol dependence, the effect size of the WHODAS II was 1.46, 1.05 and 1.35 respectively (32, 
33), showing that it is able to detect even larger changes than the fair, although comparable, ef-
fect sizes in this study.  
When interpreting sensitivity to change, floor- and ceiling effects have to be considered. The 
scale Self Care shows immense floor effects for t1 and in the majority of cases least sensitivity 
to change across subgroups. Considering the floor effects (Table 8), it can be concluded that the 
WHODAS II shows satisfactory sensitivity to change, which is comparable to that of the SF-36. If 
subjects cluster at one end of the distribution, change is not detectable. At baseline 33% to 
70.30% of patients reported best possible score in the domain Self Care, making detection of 
further improvement impossible. The floor effects for the other subscales are lower. 
The responsiveness statistics are dependent on the size of the intervention’s effect and its vari-
ance, as is obvious by their defining formulas. Without control group (group without treatment) it 
is difficult to distinguish between actual improvements or deterioration and methodological arte-
facts. One is restricted to answering the question whether WHODAS II or its subscales are able 
to detect changes at all.  
Another fundamental question has to be addressed: Does it make sense to assess Activities 
after a rehabilitation treatment of several weeks, where people do not tend to perform a job or 
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household duties? According to Zwingmann (34) questions about Activities asked directly after 
rehabilitation lead to a high rate of missing values and validity has to be seen critically. 
 
In conclusion, the WHODAS II is a useful instrument for measuring disability in musculoskeletal 
conditions, cardiovascular and general internal conditions, stroke, breast cancer and depres-
sion. It shows high reliability and validity and responsiveness scores that are comparable with 
SF-36. 
 
In 1993, Anderson et al. claimed in a review of the international adaptation and use of generic 
Health Related Quality of Life measures that progress towards cross-national measurement 
equivalence in Health Related Quality of Life (HRQL) measures has been uneven and the de-
velopment of language-adapted versions of Health Related Quality of Life measures up to that 
date have mostly concerned translation issues, within the context of independently conducted 
studies. According to the authors substantially less focus has been placed on psychometric 
equivalence across language versions. This lack of prominent differences found between coun-
tries in ranking of health states in major HRQL measures supports the feasibility of developing 
internationally applicable HRQL instruments (35). 
It seems that with development and validation of WHODAS II and its linkage to the ICF a new 
era of measuring functioning, disability and health has begun. 
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